arrow_back Civic Audit
Share share

Expanding Medical Research on Marijuana and Cannabidiol

This law simplifies the process for conducting scientific research on marijuana and cannabidiol, potentially accelerating the development of new medications. It modifies rules for obtaining research and production approvals, and allows doctors to openly discuss the potential benefits and risks of these substances with patients.
Key points
The process for obtaining approvals for marijuana and cannabidiol research has been simplified to accelerate medical discoveries.
Access to marijuana for research purposes has been increased, ensuring a consistent supply for scientists.
Doctors can now freely discuss the medical uses of marijuana and cannabidiol with patients (or their guardians) without legal concerns.
Research into the potential benefits and risks of marijuana, including its effects on the brain and cognitive abilities, is being supported.
article Official text account_balance Process page notifications_active Track this Bill
77%
VOTING RESULTS
2022-07-27
For 325
Against 95
Abstain 0
Full voting results open_in_new
gavel
Status:
Became Law
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 117_HR_8454
Sponsor: Rep. Blumenauer, Earl [D-OR-3]
Process start date: 2022-07-21
Voting date: 2022-07-27
Meeting no: 2
Voting no: 392
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Medical Marijuana and Cannabidiol Research Expansion Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_8454.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-07-21.

What are the main provisions?

Key points include:

  • The process for obtaining approvals for marijuana and cannabidiol research has been simplified to accelerate medical discoveries.
  • Access to marijuana for research purposes has been increased, ensuring a consistent supply for scientists.
  • Doctors can now freely discuss the medical uses of marijuana and cannabidiol with patients (or their guardians) without legal concerns.
  • Research into the potential benefits and risks of marijuana, including its effects on the brain and cognitive abilities, is being supported.
What is the specific legal status?

The current status is Became Law.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Where is the official voting record?

The official roll call vote is recorded at: voting record

Who is the primary sponsor?

The primary sponsor is Rep. Blumenauer, Earl [D-OR-3].

What is the latest detailed status?

The latest detailed status is: Became Public Law No: 117-215.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

What is the impact of this bill?

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health Courts and Law